机构:[1]The Lab of Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[3]Department of Health Management & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.四川省人民医院
This study is supported by the National
Natural Science Foundation of China (Grants 81771511,
82071589, and 81700044), National 137 Key R&D Program
of China (Grant 2018YFC2000400), and National Clinical
Research Center for Geriatrics, West China Hospital, Sichuan
University (Grant Z2018B04).
语种:
外文
PubmedID:
第一作者:
第一作者机构:[1]The Lab of Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yang Ming,Gong Chuhui,Song Kangping,et al.APPL1 Is a Prognostic Biomarker and Correlated with Treg Cell Infiltration via Oxygen-Consuming Metabolism in Renal Clear Cell Carcinoma[J].Oxidative medicine and cellular longevity.2023,2023:5885203.doi:10.1155/2023/5885203.
APA:
Yang Ming,Gong Chuhui,Song Kangping,Huang Ning,Chen Honghan...&Xiao Hengyi.(2023).APPL1 Is a Prognostic Biomarker and Correlated with Treg Cell Infiltration via Oxygen-Consuming Metabolism in Renal Clear Cell Carcinoma.Oxidative medicine and cellular longevity,2023,
MLA:
Yang Ming,et al."APPL1 Is a Prognostic Biomarker and Correlated with Treg Cell Infiltration via Oxygen-Consuming Metabolism in Renal Clear Cell Carcinoma".Oxidative medicine and cellular longevity 2023.(2023):5885203